Bausch Health Companies (BHC) Interest Expenses (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Interest Expenses data on file, last reported at -$552.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 267.27% year-over-year to -$552.0 million; the trailing twelve-month figure through Mar 2026 stood at -$552.0 million (down 140.35% YoY), and the FY2025 full-year result was $2.6 billion, up 12.78% from the prior year.
• Interest Expenses eased to -$552.0 million in Q1 2026, from $603.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2.4 billion in Q2 2025 to a low of -$552.0 million in Q1 2026.
• A 5-year average of $503.8 million and a median of $383.0 million in 2022 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses jumped 345.11% in 2025 and sank 267.27% in 2026, its largest moves.
• Tracing BHC's Interest Expenses over 5 years: stood at $383.0 million in 2022, then retreated by 5.22% to $363.0 million in 2023, then declined by 7.16% to $337.0 million in 2024, then soared by 78.93% to $603.0 million in 2025, then sank by 191.54% to -$552.0 million in 2026.
• Business Quant data shows BHC's Interest Expenses at -$552.0 million in Q1 2026, $603.0 million in Q4 2025, and $412.0 million in Q3 2025.